Stream Link: https://globalmeet.webcasts.com/starthere.jsp?ei=1690208&tp_key=b308ccfc59
Program Description
Diabetes is an extremely common condition worldwide, with 537 million individuals affected in 2021, which is currently on the rise. Patients with either type 1 or type 2 diabetes utilize insulin to manage their blood sugar, of which insulin pump therapy is a notable advancement in treatment technology. Insulin pump therapy can continuously infuse insulin at the proper rate to minimize adverse safety risks like hypoglycemia. While advancements in diabetes technology can improve outcomes, both providers and patients may find them difficult to implement. Insulin pump technology is rapidly progressing, which can make it overwhelming to assess the benefits and who should use them. Pharmacists can help address barriers such as complexity, patient access, and a general lack of knowledge about the technology through training and increasing awareness. This activity will cover the role of technology in managing diabetes, evaluating current and emerging insulin pump therapies and patient-specific strategies to facilitate the uptake of this technology. With a thorough understanding of novel insulin pump therapies, pharmacists can better utilize them for treatment, which can help improve quality of life and reduce diabetes’ burden.
Target audience: Retail and community pharmacists and pharmacy technicians
Type of activity: Application
Release date: October 29, 2024
Expiration date: December 29, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the role of technology in managing diabetes
- Identify current and emerging insulin pump therapies based on clinical data and guideline recommendations
- Examine patient-specific strategies to facilitate the uptake of novel diabetes technologies in eligible patients
